Mycobacterium szulgai

Jump to navigation Jump to search
style="background:#Template:Taxobox colour;"|Mycobacterium
style="background:#Template:Taxobox colour;" | Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. szulgai

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mycobacterium szulgai is a species of Mycobacterium. It is a Scotochromogen and is currently ungrouped. It is known to cause skin infections.[1]

Treatment

Antimicrobial Regimen

  • 1. in vitro susceptibility[2]
  • M. szulgai is susceptible in vitro to most antituberculous drugs including Quinolones and newer Macrolides.
  • 2. Pulmonary infection
  • Preferred regimen: three- or four-drug regimen that includes 12 months of negative sputum cultures while on therapy
  • 3. Extrapulmonary infection
  • Preferred regimen: combination antituberculous medications based on in vitro susceptibilities for 4 to 6 months

References

  1. Hizawa K, Nagata Y, Kudo T, Taniguchi M, Matsumoto T, Iida M (September 2009). "[A case of steroid-dependent ulcerative colitis complicated by skin infection of Mycobacterium szulgai]". Nippon Shokakibyo Gakkai Zasshi (in Japanese). 106 (9): 1359–63. PMID 19734708.
  2. Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007-02-15). "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases". American Journal of Respiratory and Critical Care Medicine. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. ISSN 1073-449X. PMID 17277290.